HIMS Stock Options Traders Anticipate Significant Price Volatility Ahead of Earnings Hims & Hers Health (HIMS) stock options traders are signaling a substantial price swing ahead of the company’s upcoming earnings report, with market participants pricing in a potential 14.8% move. As of the latest data, the stock is trading near $26.25, and traders are using the $26 strike price as the at-the-money straddle. The call option for the $26 strike is priced at $2.11, while the put option is at $1.78, resulting in a total cost of $3.89. This pricing suggests a projected post-earnings range of approximately $22.36 to $30.14, reflecting heightened expectations for volatility. Analysts and traders are also observing similar implied moves across nearby strike prices. The $26.50 straddle is priced at $3.87, and the $27 straddle at $4.00, reinforcing the market’s anticipation of a significant price shift. The active positioning around these key strikes indicates that traders are preparing for a sharp reaction, with the $26 call showing 1,391 contracts traded compared to 740 puts. Open interest at the $26 strike is nearly balanced, with 3,167 calls and 3,136 puts outstanding. However, the $26.50 strike leans more bullish, as 3,034 calls have been traded against only 319 puts. The options market’s focus on volatility suggests that investors are bracing for a substantial earnings outcome, rather than a minor price fluctuation. The balanced open interest near the $26 strike implies readiness for a move in either direction, while the heavier call volume at $26.50 points to increased optimism about potential upside.#hims_hers_health #hims #earnings_report #stock_options #wall_street_analysts
Apple Stock: Bank of America Remains Bullish Ahead of Earnings Bank of America has reinforced its positive outlook on Apple stock ahead of the company’s highly anticipated fiscal Q2 earnings report, highlighting the potential of the M5 chip family to drive long-term growth. The firm reiterated its Buy rating and maintained its $325 price target, which represents a 23.4% upside from Apple’s share price of $263.40 at the time of the analysis. This forecast comes as investors seek reasons to remain optimistic in a market marked by volatility, with Apple positioned as a standout due to its strong product cycle and expanding AI capabilities. The M5 chip family is central to Bank of America’s bullish case, as it significantly enhances on-device AI performance. The new chips offer over four times the GPU compute power of the M4 for AI tasks, with memory bandwidth increasing by 30% to 153GB/s. Higher-end versions, such as the M5 Pro and M5 Max, push these metrics even further, reaching 307GB/s and 614GB/s respectively. These improvements are expected to accelerate inference processes, reduce reliance on cloud computing, and lower associated costs, positioning Apple as a leader in edge AI. Bank of America analysts argue that the M5 chips represent a strategic shift for Apple, transforming its AI narrative into a broader technological advantage. Unlike previous iterations that relied heavily on dedicated neural engines, the M5 leverages Apple’s CPU, GPU, Media Engine, and memory system more directly, creating a more integrated and efficient approach to AI processing. This, combined with Apple’s resilient Services segment and the growing impact of Private Cloud Compute, strengthens the case for sustained growth.#apple #bank_of_america #m5_chip #earnings_report #private_cloud_compute
